An experimental drug for Alzheimer’s disease appears to have shown successful results in a major large-scale clinical trial. The drug’s makers announced Tuesday that their treatment slowed down people’s rate of cognitive decline in a Phase III trial. The findings will likely pave the way for the drug’s approval in the…